Loxoprofen Sodium/Methocarbamol

洛索洛芬钠/美索巴莫

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLoxoprofen Sodium/Methocarbamol

Drug Alias Name美索巴莫/洛索洛芬钠Loxoprofen/methocarbamolMethocarbamol and Loxoprofen SodiumSodium Loxoprofen/MethocarbamolLoxoprofen Sodium and Methocarbamol +[6]

ClassificationSmall molecules

Mechanisms of ActionCyclooxygenases inhibitorsCarbonic anhydrase I inhibitors

TargetsCarbonic anhydrase ICyclooxygenases

Therapy Area/IndicationsPain

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Methocarbamol Sodium Loxoprofen

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg

China Registration ClassN/A

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. Kg

Inactive CompaniesN/A

Active IndicationsPain

Inactive IndicationsN/A

Other Information

ATC CodeN/A